Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03080090 · ClinicalTrials.gov registry record · NA

YMCA Exercise Intervention for Smoking Cessation Study

A NA study, sponsored by Jasper A. Smits.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT03080090: Completed NA study, sponsored by Jasper A. Smits.

NCT03080090 is a NA study that has completed, run by Jasper A. Smits. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03080090, a NA study, has completed, sponsored by Jasper A. Smits.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

Cigarette smoking is the leading cause of death and disability in the United States. Although smoking has declined since 1964, it is still very common among some groups of people. One such group is persons with emotional symptoms and disorders. There has been little success in developing treatments for smoking cessation for smokers with affective disturbances. Recent work suggests that being sensitive to, and less tolerant of, stress is associated with many problems in daily life. People with high 'stress sensitivity' tend to use avoidant strategies to cope with their stress, like smoking. Also, people with high levels of stress sensitivity report stronger beliefs that smoking will reduce negative feelings. They also report having a harder time quitting and in fact, are less successful at doing so. This information suggests that stress sensitivity is important to target during smoking cessation treatment for smokers with affective vulnerabilities. This clinical trial will evaluate a treatment that integrates exercise to reduce stress sensitivity among high stress sensitive smokers. It builds directly from our recent work and we now seek to adapt it to a more a more accessible and sustainable application. Results will provide important information on the benefit of an integrated intervention that could be used in the community for smokers at great risk for relapse and who do not benefit from existing alternative treatments. This study is the first to test an intervention for stress sensitive smokers and has the potential to help at-risk individuals experience quitting success and, ultimately, reduce the burden of tobacco-related cancers in Texas.

Primary Outcome

Change from baseline in point prevalence abstinence (PPA) after quit attempt at week 6 of the protocol.

Interventions

  • BEHAVIORAL Smoking Cessation Intervention
  • BEHAVIORAL Aerobic exercise

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2017-04-12
Est. Completion 2020-07-06
Phase NA
Jasper A. Smits

8 total trials

What the finished NCT03080090 record still lists

NCT03080090 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which Smoking Cessation Intervention is the first listed.

NCT03080090 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03080090 about?

NCT03080090 is a clinical study titled "YMCA Exercise Intervention for Smoking Cessation Study". Cigarette smoking is the leading cause of death and disability in the United States. Although smoking has declined since 1964, it is still very common among some groups of people. One such group is persons with emotional symptoms and disorders. There has been little success in developing treatments ...

What is the current status of trial NCT03080090?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2017-04-12. Estimated completion is 2020-07-06.

What interventions are being tested in trial NCT03080090?

The interventions under investigation include: Smoking Cessation Intervention (BEHAVIORAL), Aerobic exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT03080090?

This trial is sponsored by Jasper A. Smits, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03080090's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03080090, the US trial registry maintained by the National Library of Medicine. NCT03080090 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.